Opexa Therapeutics (OPXA) Files $17.25M Common Shelf
Get Alerts OPXA Hot Sheet
Join SI Premium – FREE
Opexa Therapeutics (Nasdaq: OPXA) filed a registration with the U.S. SEC to sell, from time to time, up to $17.25 million shares of its Common Stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bluerock Acquisition Corp. II closes $172.5M IPO on Nasdaq
- LogProstyle acquires Kansai-based I-FLATZ to expand beyond Tokyo
- Webster Equity Partners to acquire Lifecore Biomedical for up to $664M
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share